BridgeBio Pharma Inc (NASDAQ:BBIO)

9.23
Delayed Data
As of Jun 24
 +0.15 / +1.65%
Today’s Change
4.98
Today|||52-Week Range
65.33
-44.66%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Momtazee James C
Director
Buy12/29/202180,000$14.50$1.2M-34.88%
Scheller Richard H
Director
Sale8/04/202113,777$53.23$733.3K-82.51%
Hassan Fred
Director
Buy12/29/202119,300$14.17$273.5K-34.88%
Saunders Brenton L
Director
Buy12/29/202117,600$14.48$254.8K-34.88%
Scheller Richard H
Director
Buy8/04/202113,777$17.00$234.2K-82.51%
Kumar Neil /bridgebio/
President & Chief Executive Officer
Sale8/16/20213,730$49.48$184.6K-81.33%
Kumar Neil /bridgebio/
President & Chief Executive Officer
Sale11/16/20213,730$47.25$176.2K-80.44%
Kumar Neil /bridgebio/
President & Chief Executive Officer
Sale5/16/202223,759$6.74$160.1K+37.09%
Daniels Ronald J
Director
Sale12/28/202111,745$12.80$150.3K-31.20%
Daniels Ronald J
Director
Buy12/28/202111,745$12.73$149.5K-31.20%
Page of 4